New drug combo aims to control Hard-to-Treat hodgkin lymphoma
NCT ID NCT03681561
First seen Jan 17, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study tests a combination of two drugs, nivolumab and ruxolitinib, in people with classical Hodgkin lymphoma that has returned or not responded to prior treatments. The goal is to find the safest dose of ruxolitinib when given with nivolumab and to see how well the combination controls the disease. About 54 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana Melvin and Bren Simon Comprehensive Cancer Center
WITHDRAWNIndianapolis, Indiana, 46202, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Illinois Cancer Center
COMPLETEDChicago, Illinois, 60612, United States
-
University of Iowa Hospitals and Clinics
ACTIVE_NOT_RECRUITINGIowa City, Iowa, 52242, United States
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53705, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.